Cough & Lung Sound Measures for Clinical Trials

The RESP® Platform
RESP Cough Monitoring System

RESP® Platform Overview

The RESP® Platform offers clinical trial teams a new approach to understanding treatment response by capturing respiratory symptoms in daily life, enabling more robust evidence generation and clearer differentiation of clinical programs.

  • Patient-Friendly: Wireless, discreet form factor and privacy-preserving
  • Multi-Parameter: Comprehensive respiratory and physiological measures
  • Validated Reporting: Automated or manual (human) overread to meet endpoint requirements
RESP Biosensor for Clinical Trials

Clients & Partners

Measures

A robust combination of multi-modal data alongside patient reported outcomes (PROs)

Cough Monitoring
          • Cough Frequency (24-hour)
          • Cough Bouts
          • Cough Sound Intensity
          • Wheeze, Rhonchi, Crackles
          • Breathing Patterns*
          • Respiratory Rate*
          • Heart Rate & Heart Rate Variability*
          • Orientation (e.g. Supine or Upright)*
          • Sleep/Wake*
          • Activity Levels*

*Measurement not FDA cleared but may be collected in clinical trials

Metrics-at-a-Glance

1.5M

Lung Sounds Captured

50M

Breaths Captured

5

Continents

34

Countries

36

Languages

245

Sites

Device Selection for Varying Applications

Digital Measures for Multiple Indications

Cough Wheeze Crackles Rhonchi Respiratory Rate* Heart Rate* Activity*
Chronic Cough
Pulmonary Fibrosis
Bronchiectasis
COPD
Asthma
Infectious Diseases
Lung Cancer
Congestive Heart Failure
  • Chronic Cough
  • IPF
  • Bronchitis
  • COPD
  • Asthma
  • RSV
  • Covid-19
  • Heart Failure

*Measurement not FDA cleared but may be collected in clinical trials

Why Include Cough & Lung Sounds as Endpoints?

  • Strengthen evidence into how patients feel and function
  • Reduce reliance on PROs to demonstrate treatment efficacy
  • Differentiate your program to patients and regulators
  • Uncover signals that may point to new or expanded indications
  • Identify new pharmacologic insights into your treatment

 

Features & Specifications

    • Wireless and discreet
    • Passive and continuous
    • Data transfer to cloud
    • 24+ hour battery life
    • Water resistant
    • Patient-privacy preserving (HIPAA compliant)
    • Flexible reporting including automated or human analysis of cough and lung sounds
    • Verifications: FDA 510(k) Class II and CE Mark  (RESP Biosensor only) 

 

Cough Monitor - RESP

Publications

Stepwise Validation Program

Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough

Poster Presentation, American Thoracic Society, 2025

Objective Cough Monitoring
Objective Cough Monitoring Detects More Patients with Cough Than Patient Self-Reporting

Poster Presentation, American Cough Conference, 2023

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Explore using the RESP® Biosensor in your next study